TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02831842 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01793935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02087592 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01363440 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02981251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01617967 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02800486 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03102619 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04209257 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01290250 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01290250 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02908009 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT03315364 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03536377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01430572 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03860350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04398134 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03041870 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study NCT03925714 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01258894 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00850642 — Safety Biomarker (SAF): Arachidonate 5-lipoxygenase activating protein
Genes: ALOX5AP; FLAP
Study NCT03982953 — Predictive Biomarker (PRD): EEF1A2 mRNA
Genes: EEF1A2; EEF1AL; STN
Study NCT01558570 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03727867 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03727867 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03727867 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03559309 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03559309 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03718260 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02916329 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05299450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04656080 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02941952 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01857154 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03388944 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00021255 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00387127 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00387127 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT00387127 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT00387127 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00387127 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03308565 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03510702 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01873833 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01873833 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00725660 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00927082 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02523638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01845493 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT00849472 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02137460 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01428128 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01428128 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04076215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04549428 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02098551 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00830570 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT02870270 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT03537677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00222274 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02958670 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00540267 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00922389 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04899128 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01445964 — Predictive Biomarker (PRD): SLCO2B1 mRNA
Genes: SLCO2B1; KIAA0880; OATP2B1; OATPB; SLC21A9
Study NCT00026676 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02113215 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00256607 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00256607 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00256607 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT04328233 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04328233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03098758 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03717363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00525408 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT00187629 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00120484 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00120484 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01452087 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03076242 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT00614393 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01588509 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02293096 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02293096 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT01750944 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01995812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00336778 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00191919 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT01433913 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT03298061 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT01590615 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01590615 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04656119 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT04656119 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study NCT00792701 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT00792701 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT02502500 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00673829 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04208711 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT04208711 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01790009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02356146 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03234452 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03234452 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03234452 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02940379 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03474744 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03147287 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03837834 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05616897 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00574899 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01709981 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04584853 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02746731 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT02867852 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04519398 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04519398 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT04519398 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02836106 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00602784 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01427946 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01386177 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03120572 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04111783 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04321499 — Predictive Biomarker (PRD): SHOX2 mRNA
Genes: SHOX2; OG12X; SHOT
Study NCT04321499 — Predictive Biomarker (PRD): PTGER4 mRNA
Genes: PTGER4; PTGER2
Study NCT02067416 — Predictive Biomarker (PRD): TLE3 mRNA
Genes: TLE3; KIAA1547
Study NCT02976727 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT02122952 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT03855371 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03855371 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00186797 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00031005 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT00031005 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00031005 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03899090 — Predictive Biomarker (PRD): REST mRNA
Genes: REST; NRSF; XBR
Study NCT00239291 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00558883 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT00558883 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03355794 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study NCT05562921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02233088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04367441 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT02416271 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02249780 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02410603 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04344093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03472599 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00369018 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT00369018 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT02845349 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT04510753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00327171 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01643187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03453970 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00138970 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT03168087 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02625012 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT01069640 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01374789 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01374789 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT03055195 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00677287 — Predictive Biomarker (PRD): RNF43 mRNA
Genes: RNF43
Study NCT00677287 — Predictive Biomarker (PRD): TOMM34 mRNA
Genes: TOMM34; URCC3
Study NCT00677287 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00677287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00677287 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01027416 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01027416 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00396669 — Safety Biomarker (SAF): DRD2
Study NCT02866383 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT03083041 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03083041 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT03083041 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01861054 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT01861054 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT01861054 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01861054 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study NCT01861054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01861054 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01861054 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01861054 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01861054 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study NCT01861054 — Predictive Biomarker (PRD): FOXC2 mRNA
Genes: FOXC2; FKHL14; MFH1
Study NCT01861054 — Predictive Biomarker (PRD): ALDH1A1 mRNA
Genes: ALDH1A1; ALDC; ALDH1; PUMB1
Study NCT01861054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01861054 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT01861054 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT01861054 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01861054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01156207 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT03699449 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT03560596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00538538 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03331562 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03331562 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT00167947 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT01975246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03246854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01302171 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04640402 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02995889 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT04517539 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00585650 — Predictive Biomarker (PRD): TNFR1B
Genes: TNFRSF1B; TNFBR; TNFR80; TNF-R75; TNF-R-II; p75; CD120b
Study NCT00585650 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05307445 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02911467 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT03368430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04184908 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT03274102 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02580552 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT03978377 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00373087 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT04084249 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04377386 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03170921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02804646 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02804646 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01968785 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02749279 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00617656 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01675336 — Safety Biomarker (SAF): Interleukin 1
Study NCT02069236 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT01817647 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02119026 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02119026 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03476512 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04799873 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03509584 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03509584 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00694161 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03274089 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00831207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00831207 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT01108055 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01108055 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02882984 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04419974 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT04419974 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study NCT04419974 — Predictive Biomarker (PRD): TNFSF14 mRNA
Genes: TNFSF14; HVEML; LIGHT; UNQ391/PRO726
Study NCT04419974 — Predictive Biomarker (PRD): FCGR3B mRNA
Genes: FCGR3B; CD16B; FCG3; FCGR3; IGFR3
Study NCT04419974 — Predictive Biomarker (PRD): CLC mRNA
Genes: CLC; LGALS10; LGALS10A
Study NCT04419974 — Predictive Biomarker (PRD): SLA mRNA
Genes: SLA; SLAP; SLAP1
Study NCT04419974 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT01584583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01461837 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01762007 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04581746 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04325945 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01764581 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02960672 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT02035293 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04370899 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03579485 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT04242238 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT04275050 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01376726 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01410604 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01410604 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01410604 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00819910 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00819910 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01264471 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02087683 — Surrogate Endpoint (SUR): Serum calcium